Work

359MO Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma

Year: 2023

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.10.467

Authors: S-S. Guo, Q.Y. Chen, L. Liu, R. Sun, P. Wang, D. Li

Institutions: Sun Yat-sen University Cancer Center, Sun Yat-sen University, State Key Laboratory of Oncology in South China

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4389280157

FWCI:

Cites:

Cited by:

Related to: 10